Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Aculys Pharma delivers positive Phase 3 clinical study interim analysis result of a diazepam nasal spray: an antiepileptic drug for the treatment of epileptic seizures 2023-10-18 14:00
WuXi XDC and HKSTP Join Forces to Promote Development of Bioconjugate Drug Industry in Hong Kong 2023-10-18 11:00
First Patient Dosed in the Registrational Phase III Study of Olverembatinib in Treatment-Naïve Patients with Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) 2023-10-18 10:11
Bridging the Healthcare Gap in Thailand and Beyond with the Belt and Road Initiative 2023-10-18 08:21
Bio4t2 announces trial evaluating repeat infusions of CAR-T targeting solid tumors without lymphodepletion 2023-10-17 23:17
Ubie's new Generative AI feature for doctors effortlessly summarizes patient findings and streamlines medical record documentation with a 90% User Satisfaction rate. 2023-10-17 23:00
SHL Medical and Lifecore Biomedical enter co-marketing partnership agreement 2023-10-17 17:00
CANbridge Announces NDA Acceptance of CAN108 (邁芮倍®/LIVMARLI®) for Cholestatic Pruritus in Progressive Familial Intrahepatic Cholestasis (PFIC) by China's National Medical Products Administration 2023-10-17 08:00
Abbisko will debut two blockbuster clinical research results at the 2023 European Society for Medical Oncology（ESMO） 2023-10-16 21:50
New Study Demonstrates Lunit SCOPE IO's Effectiveness to Predict Biliary Tract Cancer Therapy Outcomes - Findings to be Presented at the ESMO 2023 2023-10-16 21:10
TaiMed Announces Significant Progress in Clinical Trials for New HIV Treatment 2023-10-16 21:00
I-Mab Announces Phase 1 Data of Givastomig at ESMO 2023 2023-10-16 20:00
Abbisko presented two preclinical research results at the 35th International Molecular Targets and Cancer Treatment Conference (EORTC-NCI-AACR) 2023-10-16 18:20
CANbridge Announces Full Enrollment Reached in the Core Part of The CAN103 Phase 2 Trial for Gaucher Disease in China 2023-10-16 13:38
Ascentage Pharma and AstraZeneca Enter into Clinical Collaboration on the Registrational Phase III Study of Bcl-2 Inhibitor Lisaftoclax in Combination with BTK Inhibitor Acalabrutinib in Treatment-Naïve Patients with First-Line CLL/SLL 2023-10-16 09:23
Everest Medicines' Licensing Partner Pfizer Announces U.S. FDA Approves Etrasimod for Adults with Moderately to Severely Active Ulcerative Colitis 2023-10-16 07:48
Sihuan Pharmaceutical Was Selected As One Of The First Echelon Of Enterprises In The list of China's Top 100 Pharmaceutical Innovative Enterprises in 2023 2023-10-14 20:09
Nona Biosciences and INGENIA Therapeutics Enter into Collaboration Agreement 2023-10-13 23:26
Offering broader access to sustainable and scalable pharma-grade saponin adjuvants 2023-10-13 21:47
Actinogen to present progress on Phase 2 trials at the BIO Investor Forum, San Francisco and Clinical Trials on Alzheimer's Disease (CTAD) Conference, Boston 2023-10-13 20:00
1 74 75 76 77 78 413